1032943-43-3 Usage
General Description
4-Bromo-1H-pyrazolo[3,4-c]pyridine, also known as 1-Bromo-3,4-dihydropyrazolo[3,4-c]pyridine, is a chemical compound with the molecular formula C6H4BrN3. It is a pyridine derivative with a bromine atom attached to the fourth carbon of the pyridine ring. 4-Bromo-1H-pyrazolo[3,4-c]pyridine is commonly used as a building block in organic synthesis, particularly in the pharmaceutical industry for the development of potential drug candidates. It has also been studied for its potential biological activities, including its antibacterial and antifungal properties. Additionally, 4-Bromo-1H-pyrazolo[3,4-c]pyridine has been investigated for its potential use as a precursor in the synthesis of various heterocyclic compounds with potential pharmacological applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1032943-43-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,2,9,4 and 3 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1032943-43:
(9*1)+(8*0)+(7*3)+(6*2)+(5*9)+(4*4)+(3*3)+(2*4)+(1*3)=123
123 % 10 = 3
So 1032943-43-3 is a valid CAS Registry Number.
1032943-43-3Relevant articles and documents
THERAPEUTIC INHIBITORY COMPOUNDS
-
, (2018/03/26)
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting plasma kallikrein. Furthermore, the subject compounds and compositions are useful for the treatment of diseases wherein the inhibition of plasma kallikrein inhibition has been implicated, such as angioedema and the like.
3-H-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
-
Page/Page column 33-34, (2008/12/06)
The invention relates to 3-H-pyrazolopyridines according to the general formula (I) : in which A, B, D, E, Ra, R1, R2, R3, R4, R5 and q are as defined in the claims, and salts, N-oxides, solvates and prodrugs thereof, to pharmaceutical compositions comprising said 3-H-pyrazolopyridine compounds, to methods of preparing said 3-H-pyrazolopyridines, as well as to uses thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with Tie2 signalling.
